HealthData.Gov
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Background A study for pain relief therapy with 188Re-HEDP was done in patients with bone metastases secondary to breast and prostate cancer. Materials and Methods Patients received 1.3 or 2.2 GBq, in single or multiple…
- HTML
Updated Oct 29, 2026